COWZ
Quality FactorPacer US Cash Cows 100 ETF
Pacer · Tracks Pacer US Cash Cows 100 Index · Inception Dec 16, 2016
Composite score
Based on a 0.49% expense ratio.
Based on $17.59B in net assets.
Top-10 holdings represent 21.1% of net assets.
Quality Factor base · ETF wrapper · 1.93% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use COWZ in our tools
Tool · Cost
Compare COWZ's fee against another fund
Compounds the 0.49% expense ratio against a peer over decades.
Tool · Overlap
Compare COWZ's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Quality Factor funds.
Tool · TLH
Find a tax-loss harvesting partner for COWZ
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | QUALCOMM Inc | 2.67% |
| 2 | Altria Group Inc | 2.20% |
| 3 | ConocoPhillips | 2.17% |
| 4 | CVS Health Corp | 2.16% |
| 5 | Bristol-Myers Squibb Co | 2.03% |
| 6 | Ford Motor Co | 2.01% |
| 7 | Uber Technologies Inc | 2.00% |
| 8 | Pfizer Inc | 1.99% |
| 9 | Diamondback Energy Inc | 1.98% |
| 10 | Newmont Corp | 1.93% |
Compare COWZ with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open COWZ at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.